News
Clinical Trials in India have gained global attention for their rapid growth, world-class infrastructure, and access to a diverse patient population. With increasing support from regulatory bodies and ...
Experts emphasize the need for enhanced clinical trial infrastructure in community oncology to ensure equitable access to ...
14h
Vietnam Investment Review on MSNInnovent to Present Promising Phase 2 Data for Breakthrough Eye Drug IBI302 at ARVO 2025A potential game changer in the treatment of retinal disease, the novel dual-target drug shows encouraging results.
SAN ANTONIO, May 1, 2025 /PRNewswire/ -- Summit Clinical Research, LLC ("Summit"), a leading ... of key senior leaders to drive the next phase of Summit's growth. Dr. Naim Alkhouri, MD, FAASLD ...
TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), is deepening its collaboration with ...
Ingelheim, Germany, May 6, 2025 - Boehringer Ingelheim today announces the start of the JADE Phase II clinical study (NCT06769048), investigating the efficacy and safety of BI 1584862 as a potential ...
Nexalin Technology (NXL), announced the completion and launch of phases one through five of its proprietary virtual clinic and digital research ...
This milestone builds upon phase one of the virtual clinic ... we can now facilitate clinical research on the HALO™ device while preparing for broader patient adoption. By creating a seamless ...
Research and development expenses were $25.8 million for the quarter ended March 31, 2025, compared to $11.7 million for the ...
The first phase of construction is beginning on a new $2.19 billion health care, training and research facility for UNMC and ...
core cohort dose-limiting toxicity observation period in its ongoing Phase 1b/2a clinical trial. Following a review of safety and efficacy data, the Safety Review Committee (SRC) has approved dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results